50% of eligible people on statin and / due to (from memory): - wasn't offered / prescribed by a doctor - 10% denied - 30-35% stop after a short period
The board is talking about 40 million statin users … it is true … BUT it is app. (max.) 20 million ANNUALIZED patient, since the average usage is app 6 months … like in case of Vascepa.
The requested indication: - on statin (see above: 20 million annualized) BUT / PLUS - TG 135 or higher and additional risk factor
It is app. 7.5 million POTENTIAL patient
If EVERYBODY who is eligible (match to the indication) will be on V = 11.25 bn Net Revenue per year
If the same % as statin (50%) will be on V = 5.62 bn Net Revenue per year
I am not aware of any drug that was prescribed to EVERY eligible patient … 10 bn (US) Net Revenue is a wet dream.
"easily see 15M or more eventually being prescribed Vascepa" could be seen in states where marijuana was legalized … or anywhere but only with a pipe ...
Market Data 
Markets 
AI
